Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Original Research

Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study

       
Total article views   HTML views PDF downloads Totals
10,418 Dovepress* 8,387+ 1,383 9,770
PubMed Central* 2,031 357 2,388
Totals 10,418 1,740 12,158
*Since 6 December 2018

View citations on PubMed Central and Google Scholar